Little strokes fell big oaks: a case of initially ANCA‐negative eosinophilic granulomatosis with polyangiitis (EGPA)
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024
DOI: 10.1111/ddg.15483 ↗Kurz gefasst
Fallbericht in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2024. Verfasst von Deborah Maria Gregersen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Jena, Jena, Germany. Hauptthemen laut MEDLINE: Granulomatosis with Polyangiitis. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Dear Editors, Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitis which typically proceeds through three phases. The prodromal stage presents with asthma-like discomforts, the eosinophilic stage shows eosinophilic and granulomatous infiltrations with and without eosinophilia. The last stage presents with a typically ANCA-positive vasculitis.1, 2 The stages merge seamlessly into one another and are not always clearly delineated. In 40%–60% of the patients, ANCA are detectable, typically myeloperoxidase(MPO)-ANCA.2-4 In 60%–70% of cases, both ANCA+ and ANCA–, there are skin lesions. While ANCA– patients present with early and more severe lung and also cardiac involvement, ANCA+ patients suffer more frequently from kidney and neurologic involvement.4 The diagnosis is based on clinical and laboratory findings as well as the histopathological results. While the 2022 published ACR/EULAR classification criteria may be helpful, they do not provide well defined diagnostic criteria for EGPA. The diagnostic criteria used for the 2017 published Mirra-Trial are not validated.4, 5 We report on a 58-year-old male patient who discovered a "mosquito bite like pimple" on his neck that grew centrifugally to a palm-sized plaque over the next 2 to 3 weeks. Two weeks after this initial lesion, additional papules appeared on the proximal and dorsal extremities, around the shoulder, and on the lateral groins. They developed into 4 to 40 cm large bizarrely shaped or geographical plaques with well-defined borders. The initial orange and salmon-like color of the lesions developed into a livid-brown. Several plaques showed slight scaling on the margins. There was no other sign of epidermal involvement. The erythema persisted under pressure and there was a "wet woollen yarn"-like tissue increase palpable on the margin (Figure 1). The patient felt tension and itching. Topical mometasone treatment once or twice daily for 6 weeks did not lead to relevant regression. The examination of the integument showed no other skin lesions, except for the above-mentioned lesions and varicose veins on the distal lower extremity. Repeated blood testing revealed second grade renal insufficiency, asymptomatic hyperuricemia, and an elevated ANA titer of 1:320. Six months ahead of the skin lesions the patient was diagnosed with bronchial asthma, which was well controlled under daily inhalation of fluticasone and vilanterole. There was no history of other atopic diseases. We ruled out eosinophilia, borreliosis and syphilis, as well as MPO and proteinase-3 (PR3) ANCA positivity. There were no urinary abnormalities. The patient confirmed nicotine abuse of 35 pack years. A first skin biopsy alio loco was taken one month after initial appearance of the first lesion. It showed a perivascular and lymphohistiocytic infiltration with eosinophiles and less neutrophils in the upper and lower dermis. Vascular walls were thickened without leukocytoclastic signs. Singular scattered eosinophilic degenerated collagen fibers showed so called "flame figures" (Figure 2). Direct immunofluorescence showed negative results. We considered urticaria, urticaria vasculitis, Wells syndrome, eosinophilic granulomatosis with polyangiitis, and granuloma eosinophilicum faciei as potential diagnosis. Because of increasing lesions with broad differential diagnoses we took a second biopsy 3 months after the first (Figure 3). The histology showed denser perivascular and interstitial, partly granulomatous infiltration with implementation of dermal thickened leukocytoclastic vascular walls with multiple eosinophils and multinucleated gigantic cells. Because of the clear granulomatous and vasculitic signs with eosinophilic infiltration we diagnosed an eosinophilic granulomatosis with polyangiitis despite continuous absence of eosinophilia. Although Mirra-Trial and ACR/EULAR classification criteria count eosinophilia as a criterium, the newly published (2023) guidelines state that the basis for diagnosing EGPA is a vasculitis which is objectified by histopathologic examination.4 A focused examination showed enlarged mediastinal and hilar nodes on both sides, multiple subpleural noduli and micronodules in the pulmonary HR-CT (high-resolution computed tomography). Additionally, the patient presented with a positive methacholine test. BAL including lung tissue biopsies showed granulocytic and lymphocytic infiltration of the nodules without evidence of sarcoidosis. Systemic steroids were given for immunosuppression soon after the diagnosis, inducing remission. A subsequent relapse of the skin was quickly controlled through systemic treatment with azathioprine. Asthmatic discomforts were stable under inhaled glucocorticosteroids and long-acting β2-agonists. Full remission was achieved, lasting to the current day. The presented case emphasizes the necessity of repeated biopsies, especially when histologic findings appear over time (life of lesions). There are no clear clinical, laboratory, or histologic criteria for the diagnosis of EGPA. Therefore, clinical-histopathologic correlation is particularly important for this diagnosis.6 Usually, but not necessarily, patients present with eosinophilia.7 The absence of eosinophilia and the initial absence of ANCA by ELISA complicated the correct diagnosis in our case. Both the ACR/EULAR (2022) classification and the Mirra Trial diagnostic criteria emphasize blood eosinophilia in the diagnosis of EGPA.4 An early diagnosis of EGPA can interrupt progression of tissue inflammation and destruction, improve the prognosis and prevent a fatal outcome. A relevant risk of late diagnosis is due to the rarity of the disease and the absence of ANCA and/or eosinophilia. Therefore, multiple biopsies should be considered (as in our case). Six months after diagnosis, a routine check in our clinic revealed a positive ANCA titer. Indirect immunofluorescence showed a higher titer for PR3 ANCA (1:100) than for MPO ANCA (1:10). Both PR3 and MPO-ANCA were also detectable by ELISA. The patient is under close pulmonary and dermatological follow-up. Open access funding enabled and organized by Projekt DEAL. None.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University Hospital Jena, Jena, Germany.
ORCID-Profile: Deborah Maria Gregersen, Susanne Darr-Foit
Zitieren
APA
Gregersen, D. M., Darr-Foit, S., & Tittelbach, J. (2024). Little strokes fell big oaks: a case of initially ANCA‐negative eosinophilic granulomatosis with polyangiitis (EGPA). JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15483
Vancouver
Gregersen DM, Darr-Foit S, Tittelbach J. Little strokes fell big oaks: a case of initially ANCA‐negative eosinophilic granulomatosis with polyangiitis (EGPA). JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024. doi:10.1111/ddg.15483
BibTeX
@article{Gregersen2024,
author = {Gregersen, Deborah Maria and Darr-Foit, Susanne and Tittelbach, Jörg},
title = {Little strokes fell big oaks: a case of initially ANCA‐negative eosinophilic granulomatosis with polyangiitis (EGPA)},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2024},
doi = {10.1111/ddg.15483}
}
EUVIMED